Clinical Trial Update: Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase II clinical trial investigating a double dose of icotinib for brain metastases in non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• icotinib (icotinib)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Brain Metastases, Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN